Home > > > Report Detail

Global Anti-Obesity Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 08-Jan-2019
No. of pages: 128

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.

Scope of the Report:

This report focuses on the Anti-Obesity Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

The worldwide market for Anti-Obesity Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Bristol-Myers Squibb

- Eisai Company

- FlaxoSithKline plc.

- Novo Nordisk

- Alizyme

- BoehringerIngelheim GmbH

- Pfizer

- Takeda Pharmaceutical

- Rhythm Pharmaceuticals

- Shionogi USA

- Vivus

- Zafgen

- Norgine Pharmaceuticals Ltd.

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Centrally Acting Anti-obesity Drugs

- Peripherally Acting Anti-obesity Drugs

Market Segment by Applications, can be divided into

- Hospital Use

- Clinic Use

- Household

- Other

There are 15 Chapters to deeply display the global Anti-Obesity Therapeutics market.

Chapter 1, to describe Anti-Obesity Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Obesity Therapeutics, with sales, revenue, and price of Anti-Obesity Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Obesity Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Obesity Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Anti-Obesity Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Anti-Obesity Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Centrally Acting Anti-obesity Drugs
1.2.2 Peripherally Acting Anti-obesity Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Anti-Obesity Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai Company
2.2.1 Business Overview
2.2.2 Anti-Obesity Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 FlaxoSithKline plc.
2.3.1 Business Overview
2.3.2 Anti-Obesity Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novo Nordisk
2.4.1 Business Overview
2.4.2 Anti-Obesity Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Alizyme
2.5.1 Business Overview
2.5.2 Anti-Obesity Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BoehringerIngelheim GmbH
2.6.1 Business Overview
2.6.2 Anti-Obesity Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Anti-Obesity Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda Pharmaceutical
2.8.1 Business Overview
2.8.2 Anti-Obesity Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Rhythm Pharmaceuticals
2.9.1 Business Overview
2.9.2 Anti-Obesity Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shionogi USA
2.10.1 Business Overview
2.10.2 Anti-Obesity Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Vivus
2.11.1 Business Overview
2.11.2 Anti-Obesity Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zafgen
2.12.1 Business Overview
2.12.2 Anti-Obesity Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Norgine Pharmaceuticals Ltd.
2.13.1 Business Overview
2.13.2 Anti-Obesity Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Obesity Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Obesity Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Obesity Therapeutics Market Analysis by Regions
4.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5 North America Anti-Obesity Therapeutics by Countries
5.1 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Anti-Obesity Therapeutics by Countries
6.1 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Obesity Therapeutics by Countries
7.1 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8 South America Anti-Obesity Therapeutics by Countries
8.1 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Obesity Therapeutics by Countries
9.1 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
10 Global Anti-Obesity Therapeutics Market Segment by Type
10.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Centrally Acting Anti-obesity Drugs Sales Growth and Price
10.2.1 Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.2.2 Global Centrally Acting Anti-obesity Drugs Price (2013-2018)
10.3 Peripherally Acting Anti-obesity Drugs Sales Growth and Price
10.3.1 Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.3.2 Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)
11 Global Anti-Obesity Therapeutics Market Segment by Application
11.1 Global Anti-Obesity Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.1 Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Obesity Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.4 South America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.3 Anti-Obesity Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Anti-Obesity Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Anti-Obesity Therapeutics Picture
Table Product Specifications of Anti-Obesity Therapeutics
Figure Global Sales Market Share of Anti-Obesity Therapeutics by Types in 2017
Table Anti-Obesity Therapeutics Types for Major Manufacturers
Figure Centrally Acting Anti-obesity Drugs Picture
Figure Peripherally Acting Anti-obesity Drugs Picture
Figure Anti-Obesity Therapeutics Sales Market Share by Applications in 2017
Figure Hospital Use Picture
Figure Clinic Use Picture
Figure Household Picture
Figure Other Picture
Figure United States Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Type and Applications
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Company Basic Information, Manufacturing Base and Competitors
Table Eisai Company Anti-Obesity Therapeutics Type and Applications
Table Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table FlaxoSithKline plc. Basic Information, Manufacturing Base and Competitors
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Type and Applications
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Anti-Obesity Therapeutics Type and Applications
Table Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alizyme Basic Information, Manufacturing Base and Competitors
Table Alizyme Anti-Obesity Therapeutics Type and Applications
Table Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BoehringerIngelheim GmbH Basic Information, Manufacturing Base and Competitors
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Type and Applications
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anti-Obesity Therapeutics Type and Applications
Table Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Type and Applications
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rhythm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Type and Applications
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi USA Basic Information, Manufacturing Base and Competitors
Table Shionogi USA Anti-Obesity Therapeutics Type and Applications
Table Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vivus Basic Information, Manufacturing Base and Competitors
Table Vivus Anti-Obesity Therapeutics Type and Applications
Table Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zafgen Basic Information, Manufacturing Base and Competitors
Table Zafgen Anti-Obesity Therapeutics Type and Applications
Table Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Norgine Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Type and Applications
Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Anti-Obesity Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Anti-Obesity Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Anti-Obesity Therapeutics Sales by Regions (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue by Regions (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2013
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2017
Figure North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Anti-Obesity Therapeutics Sales by Countries (2013-2018)
Table North America Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Therapeutics Sales Market Share by Countries in 2013
Figure North America Anti-Obesity Therapeutics Sales Market Share by Countries in 2017
Table North America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
Table North America Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2013
Figure North America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017
Figure United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales by Countries (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
Figure Europe Anti-Obesity Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-Obesity Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Anti-Obesity Therapeutics Revenue Market Share by Countries 2017
Figure China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Anti-Obesity Therapeutics Sales by Countries (2013-2018)
Table South America Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Anti-Obesity Therapeutics Sales Market Share by Countries in 2017
Table South America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
Table South America Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-Obesity Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Anti-Obesity Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
Table Global Anti-Obesity Therapeutics Sales by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share by Type (2013-2018)
Figure Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)
Figure Global Centrally Acting Anti-obesity Drugs Price (2013-2018)
Figure Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)
Figure Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)
Table Global Anti-Obesity Therapeutics Sales by Application (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share by Application (2013-2018)
Figure Global Clinic Use Sales Growth (2013-2018)
Figure Global Household Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Anti-Obesity Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Anti-Obesity Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)
Figure South America Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)
Table Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)
Table Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)
Table Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs